Find a Doctor
888-321-DOCS
expand
Neurosurgical ICU Group
CLEAR III Clinical Trials

CLEAR III Clinical Trials

Leadership of CNI's Neurocritical Care Center recognized for their efforts in CLEAR III clinical trials studying brain injury prevention and outcome. Click on the image above for more information.

Department of Neurosurgery

Department of Neurosurgery

Neurocritical Care Treatment

The following treatments for patients with life-threatening neurological conditions are offered at The Neurocritical Care Center at North Shore-LIJ Health System's Cushing Neuroscience Institute. We provide the following treatments:

  • Intracranial pressure monitoring – A device is placed inside the head, and senses the pressure inside the skull, then sends its measurements to a recording device.
  • Brain oxygen monitoring
  • Current ultrasound techniques

24-Hour Care
A dedicated unit that provides 24-7 intensivist coverage for critically ill patients, the Neurocritical Care Center provides comprehensive care through detailed, daily teaching rounds which include nurses, residents, fellows and a multidisciplinary team of physical and occupational therapists, respiratory therapists, nutritionists and social workers. Patients are treated through multi-modality monitoring, depending on the severity of their neurologic injury. A portable CAT scan is housed in the neurosurgical ICU for patients needing emergent imaging.

Continuing Research Efforts
The experts at the Neurocritical Care Center are constantly at the forefront of innovative and ground-breaking therapies and research. The Neurocritical Care Center is recognized for its participation in the NIH-Funded CLEAR III Clinical Trial.

CLEAR III is a 500-patient, Phase-III, randomized, international clinical trial that is using a select dose of a tissue plasminogen activator (Activase®) to quickly remove blood from the ventricles of the brain in patients presenting with an intraventricular hemorrhage (IVH).  The main objective is to prevent brain injury and improve clinical outcomes. NSUH is one of more than 70 academic medical centers participating in the study, which is looking at whether this therapy can reduce mortality and improve the quality of life for patients who have suffered an IVH. If successful, it could significantly change the way IVH is treated around the world. Mr. Rivkin, RPA-C, was awarded the coordinator bronze medal in the CLEAR III 2011-2012 ThrombOlympics performance contest, for his involvement in making NSUH the second-highest enroller in the study.


To contact the Neurocritical Care Center:
Email us at neuro@nshs.edu or call us at (516) 562-3590.

Back to Top
Winners of the 2011 Patients' Choice Awards

2013 Patients' Choice Awards

Cushing Neuroscience Institute Physicians Named as Recipients of the 2013 Patients’ Choice Awards!

Continuing education

2014 America's Top Doctors®

CNI Physicians Named in 2014 Castle Connolly's America's Top Doctors.

Best Doctors 2013

2013 Best Doctors in America® List.

Neurosurgeons and Neurologists from North Shore-LIJ’s Cushing Neuroscience Institute Make the List

top